Search Results

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Event-free survival in patients with early HER2-positive breast cancer with a pathological complete response after HER2-targeted therapy: a pooled analysis by Swain, Sandra M. (Author) , Macharia, Harrison (Author) , Cortes, Javier (Author) , Dang, Chau (Author) , Gianni, Luca (Author) , Hurvitz, Sara A. (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Slamon, Dennis (Author) , Valagussa, Pinuccia (Author) , Du Toit, Yolande (Author) , Heinzmann, Dominik (Author) , Knott, Adam (Author) , Song, Chunyan (Author) , Cortazar, Patricia (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study by Perez-Garcia, Jose Manuel (Author) , Gebhart, Geraldine (Author) , Borrego, Manuel Ruiz (Author) , Schmid, Peter (Author) , Marmé, Frederik (Author) , Prat, Aleix (Author) , Dalenc, Florence (Author) , Kerrou, Khaldoun (Author) , Colleoni, Marco (Author) , Braga, Sofía (Author) , Malfettone, Andrea (Author) , Sampayo-Cordero, Miguel (Author) , Cortés, Javier (Author) , Llombart-Cussac, Antonio (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II tr... by Marmé, Frederik (Author) , Aigner, Julia (Author) , Lorenzo Bermejo, Justo (Author) , Sinn, Peter (Author) , Sohn, Christof (Author) , Jäger, Dirk (Author) , Schneeweiss, Andreas (Author) ,


    Get full text
    Article (Journal) Online Resource